Clinical Trial Update: Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing nivolumab with or without ipilimumab in advanced metastatic cancer, completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Prostate Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Parker Institute for Cancer Immunotherapy | Conditions: Advanced Metastatic Cancer, Advanced Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-17